ResMed Inc (RMD)
Summary
RMD Chart
ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market
RMD's stellar third-quarter fiscal 2025 results reflect the ongoing momentum and strong execution across all areas of its business.
ResMed: Cornering The Market In Sleep Solutions
ResMed is a dominant player in healthcare devices with strong margins, recurring revenues, and a near-monopoly, offering a compelling mix of value and growth. The company continually invests in R&D, enhancing its product portfolio, customer experience, and expanding into new markets, justifying its premium share price. Concerns about GLP-1 drugs reducing ResMed's market are countered by data suggesting increased overall health engagement, boosting interest in sleep health solutions.
ResMed Inc Dividends
| RMD In 1 weeks Estimated | Quarterly | $0.53 Per Share |
| RMD 2 months ago Paid | Quarterly | $0.53 Per Share |
| RMD 5 months ago Paid | Quarterly | $0.53 Per Share |
| RMD 8 months ago Paid | Quarterly | $0.53 Per Share |
| RMD 11 months ago Paid | Quarterly | $0.48 Per Share |
| RMD 7 Feb 2024 Paid | Quarterly | $0.48 Per Share |
ResMed Inc Earnings
| 23 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 2.32 Cons. EPS | 2.43 EPS |
| 24 Oct 2024 Date | | 2.04 Cons. EPS | 2.2 EPS |
| 1 Aug 2024 Date | | 2.07 Cons. EPS | 2.08 EPS |
| 14 May 2024 Date | | 1.91 Cons. EPS | 2.13 EPS |
| RMD In 1 weeks Estimated | Quarterly | $0.53 Per Share |
| RMD 2 months ago Paid | Quarterly | $0.53 Per Share |
| RMD 5 months ago Paid | Quarterly | $0.53 Per Share |
| RMD 8 months ago Paid | Quarterly | $0.53 Per Share |
| RMD 11 months ago Paid | Quarterly | $0.48 Per Share |
| RMD 7 Feb 2024 Paid | Quarterly | $0.48 Per Share |
| 23 Apr 2025 Date | | - Cons. EPS | - EPS |
| 22 Jan 2025 Date | | 2.32 Cons. EPS | 2.43 EPS |
| 24 Oct 2024 Date | | 2.04 Cons. EPS | 2.2 EPS |
| 1 Aug 2024 Date | | 2.07 Cons. EPS | 2.08 EPS |
| 14 May 2024 Date | | 1.91 Cons. EPS | 2.13 EPS |
ResMed Inc (RMD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has ResMed Inc ever had a stock split?
ResMed Inc Profile
| Medical Instruments & Supplies Industry | Healthcare Sector | Mr. Michael J. Farrell BE, MBA, SM CEO | NYSE Exchange | US7611521078 ISIN |
| US Country | - Employees | 13 Feb 2025 Last Dividend | 31 Aug 2010 Last Split | 2 Jun 1995 IPO Date |
Overview
ResMed Inc. is a pioneering company focused on developing, manufacturing, distributing, and marketing medical devices alongside cloud-based software applications tailored for the healthcare markets. With its operational base divided between Sleep and Respiratory Care, and Software as a Service (SaaS), ResMed is at the forefront of offering innovative solutions for managing respiratory disorders. The company's extensive product lineup and software solutions cater to both medical and consumer needs, aiming to improve patient outcomes through advanced technology and connectivity. Founded in 1989 and headquartered in San Diego, California, ResMed markets its products globally through a combination of direct sales forces and a network of distributors, targeting sleep clinics, home healthcare dealers, and hospitals.
Products and Services
- Technologies for Respiratory Disorders - ResMed offers an array of products for treating various respiratory disorders, including ventilation devices, diagnostic products, and mask systems for use in hospitals and homes. These products are complemented by headgear, accessories, and dental devices, integrating cutting-edge technology for both medical and consumer applications.
- Cloud-Based Software Informatics - The company's software solutions, such as AirView and myAir, facilitate remote monitoring and management of patient outcomes. AirView allows healthcare professionals to remotely monitor and adjust patients' device settings, while myAir, a personalized therapy management app, supports patients with sleep apnea through education, troubleshooting tools, and engagement strategies to improve compliance.
- U-Sleep Compliance Monitoring - U-Sleep is a solution designed to help home medical equipment (HME) providers streamline their sleep programs by efficiently monitoring patient compliance, an essential factor for successful therapy outcomes.
- Out-of-Hospital Software Solutions - ResMed provides various software solutions like Brightree, MatrixCare, HEALTHCAREfirst, and MEDIFOX DAN, catering to the business management and caregiving needs of HME providers, pharmacies, senior living facilities, skilled nursing facilities, and hospice organizations. These solutions include business management software, electronic health records, billing, coding services, and analytics, facilitating improved care delivery and operational efficiency.
Contact Information
